Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 76420-010

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 76420-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Structural Formula Of Cyclobenzaprine Hydrochloride. (Cyclobenzaprine Tablets 1)

Chemical structure of Cyclobenzaprine Hydrochloride, showing its molecular framework as part of the FDA label submission details for the 7.5 mg film-coated oral tablet manufactured by Asclemed USA, Inc.*

FDA Label Image

Spl-cyclobenzaprine-7.5mg-label (Spl Cyclobenzaprine 7.5mg Label)

Labels for Cyclobenzaprine Hydrochloride Tablets, USP 7.5 mg, film-coated oral tablets, packaged by Enovachem Pharmaceuticals and distributed by SA3, LLC. The image shows two labels for NDC 76420-010-30 with a quantity of 30 tablets and NDC 76420-010-60 with a quantity of 60 tablets. Each label includes packaging and storage information, lot and batch placeholders, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.